{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T02:10:09Z","timestamp":1740622209758,"version":"3.38.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Medical University of Warsaw","doi-asserted-by":"publisher","award":["WF5\/N\/2024"],"award-info":[{"award-number":["WF5\/N\/2024"]}],"id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jchromb.2024.124443","type":"journal-article","created":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T06:46:56Z","timestamp":1735454816000},"page":"124443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A simple HPLC-UV method for monitoring therapeutic adherence in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"1252","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4552-0021","authenticated-orcid":false,"given":"Pawe\u0142 K.","family":"Kunicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej T.","family":"Grymm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Pawi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Szulczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Walig\u00f3ra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Kope\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2022","key":"10.1016\/j.jchromb.2024.124443_b0005","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jchromb.2024.124443_b0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jchromb.2024.124443_b0015","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"360","author":"Thenappan","year":"2018","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jchromb.2024.124443_b0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02334-2021","article-title":"The physiological basis of pulmonary arterial hypertension","volume":"59","author":"Naeije","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jchromb.2024.124443_b0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40256-018-0272-5","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"18","author":"Burks","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs."},{"key":"10.1016\/j.jchromb.2024.124443_b0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12170-020-00663-3","article-title":"Management of pulmonary arterial hypertension","volume":"15","author":"Mayeux","year":"2021","journal-title":"Curr. Cardiovasc. Risk Rep."},{"key":"10.1016\/j.jchromb.2024.124443_b0035","first-page":"887","article-title":"Review of bosentan in the management of pulmonary arterial hypertension","volume":"3","author":"Gabbay","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.jchromb.2024.124443_b0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40256-016-0188-x","article-title":"Macitentan: a review in pulmonary arterial hypertension","volume":"16","author":"Keating","year":"2016","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.jchromb.2024.124443_b0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.rmed.2018.09.002","article-title":"Titration of pulmonary arterial hypertension therapeutics: experience-based recommendations","volume":"143","author":"Lombardi","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.jchromb.2024.124443_b0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40262-017-0604-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of riociguat","volume":"57","author":"Frey","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2024.124443_b0055","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0006-2024","article-title":"Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review","volume":"33","author":"Le Bozec","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jchromb.2024.124443_b0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1074248419877409","article-title":"Treatment discontinuation or interruption in pulmonary arterial hypertension","volume":"25","author":"Narechania","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2024.124443_b0065","doi-asserted-by":"crossref","DOI":"10.1111\/hex.13995","article-title":"Patient readiness for shared decision making about treatment: conceptualisation and development of the ready (SDM)","volume":"27","author":"Keij","year":"2024","journal-title":"Health Expect."},{"key":"10.1016\/j.jchromb.2024.124443_b0070","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00299-2020","article-title":"Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension","volume":"6","author":"Kjellstrom","year":"2020","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.jchromb.2024.124443_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217798","article-title":"High rates of medication adherence in patients with pulmonary arterial hypertension: an integrated specialty pharmacy approach","volume":"14","author":"Shah","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2024.124443_b0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jpba.2013.11.007","article-title":"Simultaneous microdetermination of bosentan, ambrisentan, sildenafil, and tadalafil in plasma using liquid chromatography\/tandem mass spectrometry for pediatric patients with pulmonary arterial hypertension","volume":"89","author":"Yokoyama","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124443_b0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpba.2017.05.052","article-title":"Simultaneous quantification of endothelin receptor antagonists and phosphodiesterase 5 inhibitors currently used in pulmonary arterial hypertension","volume":"143","author":"Enderle","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124443_b0090","first-page":"236","article-title":"Simultaneous LC-MS analysis of plasma concentrations of sildenafil, tadalafil, bosentan, ambrisentan, and macitentan in patients with pulmonary arterial hypertension","volume":"75","author":"Tanaka","year":"2020","journal-title":"Pharmazie"},{"key":"10.1016\/j.jchromb.2024.124443_b0095","doi-asserted-by":"crossref","first-page":"e4787","DOI":"10.1002\/bmc.4787","article-title":"Simultaneous quantification of ambrisentan, macitentan and sitaxentan in human plasma using UPLC-MS\/MS","volume":"34","author":"van de Velde","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2024.124443_b0100","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/elps.202000135","article-title":"Sensitive CE-MS method for monitoring of riociguat and desmethylriociguat levels in human serum","volume":"41","author":"Hlo\u017eek","year":"2020","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jchromb.2024.124443_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894019898031","article-title":"Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice","volume":"10","author":"Michalickov\u00e1","year":"2020","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.jchromb.2024.124443_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123454","article-title":"Determination and pharmacokinetic study of riociguat by UPLC-MS\/MS in human plasma","volume":"1210","author":"Kocak","year":"2022","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2024.124443_b0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4155\/bio.14.257","article-title":"Determination of riociguat and its major human metabolite M-1 in human plasma by stable-isotope dilution LCMS\/MS","volume":"7","author":"Gnoth","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2024.124443_b0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-4347(00)00386-8","article-title":"Simultaneous determination of bosentan and its three major metabolites in various biological matrices and species using narrow bore liquid chromatography with ion spray tandem mass spectrometric detection","volume":"749","author":"Lausecker","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2024.124443_b0125","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/BF02493366","article-title":"Evolving bioanalytical methods for the cardiovascular drug bosentan","volume":"55","author":"Dell","year":"2002","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2024.124443_b0130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jpba.2012.06.027","article-title":"Development of an SPE-LC-MS\/MS method for simultaneous quantification of bosentan and its active metabolite hydroxybosentan in human plasma to support a bioequivalence study","volume":"70","author":"Parekh","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124443_b0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2011.12.012","article-title":"Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the sample card and prep DBS system","volume":"885\u2013886","author":"Ganz","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2024.124443_b0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpba.2014.03.011","article-title":"Simultaneous determination of bosentan and glimepiride in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study","volume":"95","author":"Qiu","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124443_b0145","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchromb.2015.07.053","article-title":"Simultaneous determination of macitentan and its active metabolite in human plasma by liquid chromatography-tandem mass spectrometry","volume":"1002","author":"Yu","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2024.124443_b0150","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4502","article-title":"A novel, rapid and sensitive UPLC-MS\/MS method for the determination of macitentan in patients with pulmonary arterial hypertension","volume":"33","author":"Albayrak","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2024.124443_b0155","first-page":"752","article-title":"Bioanalytical method validation for determination of macitentan in K2EDTA human plasma by LC-MS\/MS","volume":"10","author":"Purushothaman","year":"2017","journal-title":"Int. J. Chemtech. Res."},{"key":"10.1016\/j.jchromb.2024.124443_b0160","first-page":"43","article-title":"Development and validation of bioanalytical method for macitentan in human plasma using liquid chromatography-tandem mass spectrometry","volume":"8","author":"Patel","year":"2018","journal-title":"Int. J. Pharm. Chem. Biol. Sci."},{"key":"10.1016\/j.jchromb.2024.124443_b0165","unstructured":"ICH guideline M10 on bioanalytical method validation and study sample analysis, 2022, https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf."},{"key":"10.1016\/j.jchromb.2024.124443_b0170","unstructured":"Bioanalytical method validation. Guidance for industry, 2018, https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:44:15Z","timestamp":1740620655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224004525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"alternative-id":["S1570023224004525"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124443","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A simple HPLC-UV method for monitoring therapeutic adherence in pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124443"}}